Readiness and Progress in Emotion Regulation Therapy

Conditions

• Anxiety
• Depression
• Distress, Emotional
• Rumination
• Self-Criticism
• Worry

Eligibility Criteria

Sex

ALL

Age

18 Years - 65 Years

Healthy Volunteers

Not accepted

Interventions

• Emotion Regulation Therapy via Telehealth — BEHAVIORAL
  The initial stage of treatment focuses on psychoeducation about anxiety/depression, the impact that these cognitions/behaviors/emotions have on recent situations, and self-monitoring of worry/anxiety/depression. The sessions focus on the development of skills that help understand and regulate one's emotional experience (i.e., recognizing emotions when they are happening, identifying the meaning of a given emotion experience, soothing oneself in the context of negative emotional experiences). Following the development of these skills, sessions focus on the application of somatic awareness and emotion regulation skills while imagining emotionally evocative themes. The remaining session focuses on terminating therapy, relapse prevention, and future goals. An Internet-based online platform will be used to promote engagement with and increase accessibility to between-session skills practice and treatment-related activities (e.g., self-monitoring, session summaries, worksheets).

Study Details

This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

Key Dates

Start date

Oct 24, 2025

Status verified

Mar 2026

Primary completion

Aug 1, 2028

Completion

Sep 1, 2028

Study Design

Enrollment

36 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Treatment
  All participants will receive a 6-module, time-variable version of Emotion Regulation Therapy delivered weekly via synchronous telehealth using videoconferencing software and an asynchronous Internet-based online platform to supplement the content covered in each session.

Primary Outcome Measure

Weekly Assessment of Change in Attentional Control [ Time Frame: Weekly from Baseline (2 weeks) through Treatment (12-22 weeks) and Follow-Up (4 weeks) ]

Central Contacts

• Douglas S Mennin
  212.678.6609
  [email protected]
• Moises Hernandez
  212.678.6609
  [email protected]

Locations (1)

Find similar trials in New York, NY

Related Studies

• Lay-Delivered Behavioral Activation in Senior Centers
  Recruiting · University of Washington · Brandon, Florida
• Safe Mothers, Safe Children Initiative
  Recruiting · New York University · New York, New York
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
• Accelerated TMS for Depression and OCD
  Recruiting · Weill Medical College of Cornell University · New York, New York